Effect of Mucopolysaccharide Polysulfate on Sweating Function and Skin Dryness in a Mouse Model of Streptozotocin-Induced Diabetes.
Abstract
Introduction
Asteatosis is characterized by reduced water content in the stratum corneum. Patients with diabetes have been reported to experience reduced sweating, potentially leading to asteatosis. A common treatment approach for asteatosis is the use of moisturizers, such as mucopolysaccharide polysulfate (MPS) cream. However, the therapeutic mechanism of MPS in diabetes-induced asteatosis remains unknown. In this study, we investigated the role of sweating in the pathophysiology of asteatosis in diabetes and to confirm the therapeutic effect of MPS cream using a streptozotocin (STZ)-induced diabetic mouse model (STZ-DM mice).Methods
STZ-DM mice were generated by administering STZ to C57BL/6JJcl mice. Approximately 2 weeks after STZ administration, sweating function and skin surface hydration in the footpads, where sweat glands are located, were evaluated, with or without topical occlusive application of moisturizers including MPS cream for more than 10 days.Results
After STZ treatment, sweating function in STZ-DM mice gradually decreased from week 3 to 9. Furthermore, skin surface hydration and sweating function decreased over time. Topical application of MPS cream alleviated diminished sweating and skin surface hydration in STZ-DM mice. Moreover, pilocarpine-induced sweating response was attenuated in STZ-DM mice, indicating that impairment of sweating function in these mice involves neuropathic dysfunction. Topical application of MPS cream improved the pilocarpine-induced sweating response.Conclusion
The effects of MPS on the increasing water content of SC in STZ-DM mice may be partly mediated by sweating. This is the first study to demonstrate that the ameliorative effect of MPS on diabetic dry skin is mediated by enhanced sweating via neuropathy inhibition.
Related
- Progesterone restores mitochondrial bioenergetic function in streptozotocin- and amyloid-β-challenged HT-22 hippocampal cells: An in vitro model of Alzheimer's disease
- Effects of Chamaecostus cuspidatus leaf extract and p-coumaric acid on diabetes-associated vascular injury in high-fat diet/streptozotocin- induced wistar rats
- Effects of N-Acetylcysteine and Glycine Administration on Serum Levels of Soluble Suppressor of Tumorigenicity 2 and Cardiac Morphological Characteristics in an Animal Model of Streptozotocin-Induced Diabetes.
- Effect of continuous direct current on sweating and quality of life in women with primary palmar hyperhidrosis: a randomized controlled trial
- Albuminuria, kidney function, and automatically quantified retinal vascular phenotypes in hospitalized adults with type 2 diabetes
BibTeX
@article{sugimoto2026effect,
title = {{Effect of Mucopolysaccharide Polysulfate on Sweating Function and Skin Dryness in a Mouse Model of Streptozotocin-Induced Diabetes.}},
author = {Wataru Sugimoto and Hironobu Ishimaru and Sanae Hirota and Ryo Tadakuma and Ryo Aikawa and Rina Furumoto and Takaaki Doi and Yuhki Ueda},
journal = {Skin pharmacology and physiology},
year = {2026},
month = oct,
doi = {10.1159/spp/aetag005},
url = {https://europepmc.org/article/MED/42858296},
note = {CC BY},
}
RIS
TY - JOUR
TI - Effect of Mucopolysaccharide Polysulfate on Sweating Function and Skin Dryness in a Mouse Model of Streptozotocin-Induced Diabetes.
AU - Wataru Sugimoto
AU - Hironobu Ishimaru
AU - Sanae Hirota
AU - Ryo Tadakuma
AU - Ryo Aikawa
AU - Rina Furumoto
AU - Takaaki Doi
AU - Yuhki Ueda
PY - 2026
DA - 2026/10/10
JO - Skin pharmacology and physiology
DO - 10.1159/spp/aetag005
UR - https://europepmc.org/article/MED/42858296
AB - Introduction Asteatosis is characterized by reduced water content in the stratum corneum. Patients with diabetes have been reported to experience reduced sweating, potentially leading to asteatosis. A common treatment approach for asteatosis is the use of moisturizers, such as mucopolysaccharide polysulfate (MPS) cream. However, the therapeutic mechanism of MPS in diabetes-induced asteatosis remains unknown. In this study, we investigated the role of sweating in the pathophysiology of asteatosis in diabetes and to confirm the therapeutic effect of MPS cream using a streptozotocin (STZ)-induced diabetic mouse model (STZ-DM mice).Methods STZ-DM mice were generated by administering STZ to C57BL/6JJcl mice. Approximately 2 weeks after STZ administration, sweating function and skin surface hydration in the footpads, where sweat glands are located, were evaluated, with or without topical occlusive application of moisturizers including MPS cream for more than 10 days.Results After STZ treatment, sweating function in STZ-DM mice gradually decreased from week 3 to 9. Furthermore, skin surface hydration and sweating function decreased over time. Topical application of MPS cream alleviated diminished sweating and skin surface hydration in STZ-DM mice. Moreover, pilocarpine-induced sweating response was attenuated in STZ-DM mice, indicating that impairment of sweating function in these mice involves neuropathic dysfunction. Topical application of MPS cream improved the pilocarpine-induced sweating response.Conclusion The effects of MPS on the increasing water content of SC in STZ-DM mice may be partly mediated by sweating. This is the first study to demonstrate that the ameliorative effect of MPS on diabetic dry skin is mediated by enhanced sweating via neuropathy inhibition.
SN - 1660-5527
SN - 1660-5535
ER -